Hyloris Pharmaceuticals SA (EBR:HYL)
6.46
+0.14 (2.22%)
Mar 9, 2026, 1:50 PM CET
Hyloris Pharmaceuticals Market Cap
Hyloris Pharmaceuticals has a market cap or net worth of €176.96 million as of March 9, 2026. Its market cap has increased by 14.91% in one year.
Market Cap
176.96M
Enterprise Value
159.49M
Revenue
8.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
€6.46
Market Cap Chart
Since June 29, 2020, Hyloris Pharmaceuticals's market cap has decreased from 244.70M to 176.96M, a decrease of -27.68%. That is a compound annual growth rate of -5.54%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Onward Medical | 221.51M |
| European Medical Solutions | 22.43M |
| Celyad Oncology | 16.56M |
| Financière de Tubize | 10.06B |
| BioSenic | 1.63M |
| argenx SE | 38.31B |
| UCB SA | 49.09B |
| Oxurion NV | 392.55K |